Cart
World Top 10 Noninvasive Diagnostics Market - Opportunities and Forecasts, 2019-2026
|
LI_1869
|
Pages: NA
|
Jul 2019 |
14723 Views
|
|
|
|
Author(s) :
NA
|
Tables: NA
|
Charts: NA
|
Formats*:
|
|
Non-invasive diagnostics is a process of identifying the disease conditions with minimal incision to the body during diagnosis. Non-invasive diagnostic market is segment of diagnostic market, which was valued at approximately $46 billion in 2011. The non-invasive diagnostic market is mainly driven by increasing rate of prevalence of chronic disease such as CVD, Neurological disease. More than 64.4 million people are suffering from various type of CVD in the U.S, out of which nearly 2,600 people die in a day. The growth of non-invasive diagnostics market has been hindered by availability of non-invasive diagnostic services. Developing countries are not getting non-invasive diagnostic services due to lack of awareness.
Companies involved in manufacturing of non-invasive diagnostic tools are facing challenges because of increasing complexity of diseases. Diagnostic devices used in identification of neurological diseases require some amount of incision that make diagnostic process complex. In order to overcome these problem companies are conducting research on improving diagnostic process in neurological diseases. This report provides strategic intelligence of key developmental strategies adopted by key market players engaged in this business. The report gives patent analysis of the granted patent according to geographies.
The key companies included in the report are: Arthrocare Corp , Charles Russell Bard Inc , Boston Scientific Corporation , Depuy Spine Inc , Hansen Medical , Intuitive Surgical Inc , Karl Storz Endoscope Berlin Gmbh , Pentax Medical Company , Stryker Corporation , Teleflex Medical
Key Benefits
- Key developmental strategies adopted by top market players engaged in this business so that companies involved in development of non-invasive diagnostic device can get competitive intelligence of their competitors
- Market estimation for application, device and geographic segment is derived from current market scenario and expected market trends.
- Market attractiveness analysis has been included for various product segments, technologies, and geographic regions with detailed analysis of factors responsible for rapid growth of the market segments
- In depth analysis of key market drivers, restraints and opportunities of non-invasive diagnostic market with impact analysis
- Value chain analysis, Porter’s five forces model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report so that management receives clear picture of current of market scenario
MARKET SEGMENTS
GLOBAL MARKET, BY TECHNOLOGIES
- Endoscopic devices
- Electronic surgical devices
- Imagining technologies
- Monitoring and Tracking devices
- Others
GLOBAL MARKET, BY APPLICATIONS
- CVD surgery
- Gastrointestinal Surgery
- Obesity Surgery
- Cosmetic surgery
- Orthopedic surgery
- Cryosurgery
- Laparoscopic surgery
- Others
GLOBAL MARKET, BY GEOGRAPHIES
- North America
- Europe
- Asia-Pacific
- ROW
KEY AUDIENCES
- Medical device manufacturing companies
- Pharmaceutical companies
- Research Institutes
- Academic Institutes
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH THERAPEUTIC CLASSOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS/ TOP PLAYER POSITIONING, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 TOP 10 NONINVASIVE DIAGNOSTICS MARKET, BY TECHNOLOGIES
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. X-RAY
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. ULTRASOUND
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. MAGNETIC RESONANCE IMAGING (MRI)
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. COMPUTED TOMOGRAPHY
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. BONE DENSITOMETRY
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. NUCLEAR IMAGING
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. MAMMOGRAPHY
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. LIQUID BIOPSY
4.9.1. Key market trends, growth factors and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. ENDOSCOPY
4.10.1. Key market trends, growth factors and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
4.11. ELECTROCARDIOGRAPH (ECG)
4.11.1. Key market trends, growth factors and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country
CHAPTER 5 TOP 10 NONINVASIVE DIAGNOSTICS MARKET, BY REGION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. NORTH AMERICA
5.2.1. Key market trends, growth factors and opportunities
5.2.2. North America top 10 noninvasive diagnostics market, by country
5.2.2.1. U.S. top 10 noninvasive diagnostics market size and forecast, by technologies
5.2.2.2. Canada 10 noninvasive diagnostics market size and forecast, by technologies
5.2.2.3. Mexico 10 noninvasive diagnostics market size and forecast, by technologies
5.2.3. North America top 10 noninvasive diagnostics market, by technologies
5.3. EUROPE
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Europe top 10 noninvasive diagnostics market, by country
5.3.2.1. Germany top 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.2. France 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.3. UK 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.4. Italy top 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.5. Spain 10 noninvasive diagnostics market size and forecast, by technologies
5.3.2.6. Rest of Europe 10 noninvasive diagnostics market size and forecast, by technologies
5.3.3. Europe top 10 noninvasive diagnostics market, by technologies
5.4. ASIA-PACIFIC
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Asia-Pacific top 10 noninvasive diagnostics market, by country
5.4.2.1. Japan top 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.2. China 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.3. India 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.4. Australia top 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.5. South Korea 10 noninvasive diagnostics market size and forecast, by technologies
5.4.2.6. Rest of Asia-Pacific 10 noninvasive diagnostics market size and forecast, by technologies
5.4.3. Asia-Pacific top 10 noninvasive diagnostics market, by technologies
5.5. LAMEA
5.5.1. Key market trends, growth factors and opportunities
5.5.2. LAMEA top 10 noninvasive diagnostics market, by country
5.5.2.1. Brazil top 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.2. Saudi Arabia 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.3. South Africa 10 noninvasive diagnostics market size and forecast, by technologies
5.5.2.4. Rest of LAMEA 10 noninvasive diagnostics market size and forecast, by technologies
5.5.3. LAMEA top 10 noninvasive diagnostics market, by technologies
CHAPTER 6 COMPANY PROFILES
6.1. GE HEALTHCARE
6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments
6.2. PHILIPS HEALTHCARE
6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments
6.3. HITACHI MEDICAL CORPORATION
6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments
6.4. HOLOGIC, INC.
6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments
6.5. SIEMENS HEALTHCARE
6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments
6.6. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments
6.7. SHIMADZU CORPORATION
6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments
6.8. TOSHIBA MEDICAL SYSTEMS CORPORATION
6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments
6.9. ESAOTE S.P.A
6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments
6.10. FUJIFILM CORPORATION
6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments
6.11. F. HOFFMANN-LA ROCHE AG
6.11.1. Operating business segments
6.11.2. Business pertherapeutic classance
6.11.3. Key strategic moves and developments
6.12. BIO-RAD LABORATORIES, INC.
6.12.1. Operating business segments
6.12.2. Business pertherapeutic classance
6.12.3. Key strategic moves and developments
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
REQUEST TOC/SAMPLE
Purchase Full Report of
World Top 10 Noninvasive Diagnostics Market- Opportunities and Forecasts, 2019-2026
- Online Only
-
$3456$3110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- 20% free customization (Pre-Sale)
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
-
$3840$3456 - Restricted to one authorized user
- One print only
- Available in Excel
- 20% free customization (Pre-Sale)
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
-
$5370$4833 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- 20% free customization (Pre-Sale)
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
-
$6450$5805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- 20% free customization (Pre-Sale)
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF -
$8995$8096 - Unlimited within company/enterprise
- Available in Excel & PDF
- 20% free customization (Pre-Sale)
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Buy Full Version
"World Top 10 Noninvasive Diagnostics Market"
Purchase Enquiry